Wockhardt Ltd. is a prominent pharmaceutical company that engages in the development, manufacture, and distribution of pharmaceutical and biopharmaceutical formulations. Catering to global healthcare needs, it operates in segments such as generic drugs, biotechnology, and new chemical entities (NCEs). Wockhardt's primary focus is on improving patient health through innovative medications in therapeutic areas like cardiology, neurology, and infectious diseases. As a key player in the pharmaceutical industry, the company also emphasizes research-driven initiatives to address unmet medical needs. With facilities that are US FDA approved, Wockhardt exports its products to markets across the United States, Europe, and Asia, significantly contributing to global healthcare solutions while adhering to stringent quality standards and regulatory requirements.